Dr. Terete Borrás is an ocular molecular biologist with an interest in gene therapy. She received her PhD in Molecular Biology at the University of Madrid (Spain) under a collaborative agreement with Purdue University, Indiana (USA). She trained at the National Eye Institute (NIH) and became one of its Principal Investigator for four years. She joined the Ophthalmology faculty at Duke University and is currently a Professor of Ophthalmology and Director of Research at the University of North Carolina at Chapel Hill. Her research focuses on the search for alternative, long-term treatments of glaucoma. She has pioneered new strategies for delivering genes to the human trabecular meshwork and identified several candidates that reduce intraocular pressure (IOP). She developed large and small animal models for studying elevated IOP using gene transfer and gene editing. She has published extensively in peered-review journals and received the American Glaucoma Society and the Robert Ritch awards. Her goals are to translate her molecular approaches into new safer gene/drugs for glaucoma.

Editorial Board
Terms of Appointment: April 2020 - March 2022